From preclinic to clinic: CEN Nutriment and ETAP-Lab new partnership for a global offer to health-nutrition R&D
CEN Nutriment and ETAP-Lab are pleased to announce they go into partnership to propose a global advice and service offer aimed at allowing their clients to meet EFSA requirement regarding scientific files for Health-Claims. ETAP-Lab proposes a large scale of preclinical trials to assess the safety and efficacy of products with potential health benefits. CEN Nutriment attains the next milestone by developing and performing clinical trial and observational studies to evaluate health claims of these products. The complementary experience shared by both societies allows to elaborate
New contracts on toxicology signed this month
ETAP has signed several toxicity contracts including a sub chronical 90-days study by oral administration and two other contracts are already in discussion.
New article co-written by ETAP-Lab published in Journal of Medicinal Food.
Publication of a new article co-written by ETAP-Lab in the field of Visceral Pain: “Benefits of preventive administration of Chlorella sp. on visceral pain and cystitis induced by a single administration of cyclophosphamide in female Wistar rat”, Journal of Medicinal Food 19(5):450-6, 2016
New article co-written by ETAP-Lab accepted by Journal of Medicinal Food
A new article co-written by ETAP-Lab in the field of Visceral Pain and entitled “Benefits of preventive administration of Chlorella sp. on visceral pain and cystitis induced by a single administration of cyclophosphamide in female Wistar rat”, was recently accepted in the Journal of Medicinal Food.
ETAP-Lab will participate to the 11th edition of JAS on June 15 & 16 in La Rochelle (France), represented by Pascale ROZAN and Jean-François BISSON
ETAP-Lab will participate to the 11th edition of JAS in La Rochelle in collaboration with CEN Nutriment. You can contact us for scheduling a meeting there with Pascale ROZAN or Jean-François BISSON . Visit our Stand: ETAP-Lab / CEN Nutriment.
New article co-written by ETAP-Lab published in Journal of Functional Foods
A new article co-written by Nicolas Violle and Jean-François Bisson in the field of Hypertension and entitled “Evidence for an antihypertensive effect of a land snail (Helix aspersa) by-product hydrolysate – Identification of involved peptides”, was recently published in the peer-reviewed Journal of Functional Foods (February 12, 2016).
Participation of ETAP-Lab to the FIE 2015 in Paris.
Jean-François BISSON, Scientific Director of ETAP-Lab, will attend the FIE in Paris on December 3, 2015. You can contact Jean-François BISSON for scheduling a meeting. For more information about this meeting click here.
New article co-written by ETAP-Lab accepted for publication in Neurotoxicology
A new article co-written by Jean-François BISSON (Scientific Director ETAP-Lab) and Sophie HIDALGO-LUCAS (Research Assistant ETAP-Lab) in the field of Toxicology and entitled “Behavioral toxicity and physiological changes from repeated exposure to fluorene administered orally or intraperitoneally to adult male Wistar rats: a dose-response study”, was recently accepted for publication in the international peer-reviewed journal Neurotoxicology (IF = 3.379).
New article co-written by ETAP-Lab published in PRIME International Journal of Aesthetic and Anti-Ageing Medicine
A new article co-written by Jean-François BISSON (Scientific Director ETAP-Lab) in the field of Dermatology and entitled “Anti-inflammatory and skin repair treatments with d-limonene”, was recently published in the peer-reviewed International Journal of Aesthetic and Anti-Ageing Medicine (November 17, 2015).
ETAP will participate to BIOFIT 2015 on December 1st & 2nd in Strasbourg (France), represented by Nicolas VIOLLE (CEO) and Jean-François BISSON (Scientific Director)
ETAP will participate to BIOFIT 2015 on December 1st & 2nd in Strasbourg. You can contact us for scheduling a meeting there with Nicolas VIOLLE (CEO) and Jean-François BISSON (Scientific Director). For more information about this meeting click here.